免疫蛋白診斷測試市場規模、佔有率、成長分析、按測試、按應用、按技術、按最終用途、按分銷管道、按地區 - 按行業預測，2024-2031 年

2022年，免疫蛋白診斷測試的全球市場規模為90億美元，從2023年的96.7億美元成長到2031年的172.6億美元，在預測期（2024-2031年）預計將以複合年成長率成長。

在感染疾病和慢性病患病率上升以及人們對早期疾病檢測重要性的認知不斷提高的推動下，全球免疫蛋白診斷測試市場正在顯著成長。重大技術進步，特別是酵素結合免疫吸附檢測法（ELISA）和化學冷光免疫檢測等診斷技術的進步，顯著提高了基於蛋白質的診斷的準確性和效率。人口老化和醫療保健支出的增加進一步推動了這種擴張。然而，成本限制和嚴格的監管標準等潛在障礙可能會阻礙市場進步。總體而言，對準確、快速診斷工具不斷成長的需求正在推動有效疾病管理和明智治療決策所需的市場動力。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析

免疫蛋白診斷測試市場規模：按測試和複合年成長率（2024-2031）

• 市場概況
• 補體系統蛋白診斷測試
• 免費輕鏈診斷測試
• 結合球蛋白診斷測試
• 免疫球蛋白診斷測試
• 前白蛋白診斷測試
• C反應蛋白（CRP）診斷測試

免疫蛋白診斷測試市場規模：按應用和複合年成長率（2024-2031）

• 市場概況
• 傳染病檢查
• 腫瘤檢查
• 內分泌檢查
• 毒性試驗
• 過敏測試
• 自體免疫疾病檢測

免疫蛋白診斷測試市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 免疫檢測
• 酵素免疫分析法
• 化學冷光分析
• 螢光測定
• 免疫比濁法
• 免疫蛋白電泳

免疫蛋白診斷測試市場規模：依最終用途及複合年成長率（2024-2031）

• 市場概況
• 醫院和診所
• 診斷實驗室
• 其他

免疫蛋白診斷測試市場規模：按分銷管道和複合年成長率（2024-2031）

• 市場概況
• 直接競標
• 零售

免疫蛋白診斷測試市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

結論和建議

Global Immunoprotein Diagnostic Testing Market size was valued at USD 9.0 billion in 2022 and is poised to grow from USD 9.67 billion in 2023 to USD 17.26 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global immunoprotein diagnostic testing market is witnessing remarkable growth, propelled by the rising prevalence of infectious and chronic diseases alongside enhanced awareness of the importance of early disease detection. Key technological advancements, particularly in diagnostic methodologies like enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays, have significantly improved the accuracy and efficiency of protein-based diagnostics. The expansion is further supported by an aging population and rising healthcare spending. Nonetheless, potential barriers such as cost constraints and stringent regulatory standards could hinder market progress. Overall, the increasing demand for precise and rapid diagnostic tools is driving market momentum, essential for effective disease management and informed therapeutic decision-making.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoprotein Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoprotein Diagnostic Testing Market Segmental Analysis

Global Immunoprotein Diagnostic Testing Market is segmented by test, application, technology, end use, distribution channel and region. Based on test, the market is segmented into complement system proteins diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests and c-reactive protein (CRP) diagnostic tests. Based on application, the market is segmented into infectious disease testing, oncology testing, endocrine testing, toxicology testing, allergy testing and autoimmune disease testing. Based on technology, the market is segmented into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay and immunoprotein electrophoresis. Based on end use, the market is segmented into hospitals and clinics, diagnostic laboratories and others. Based on distribution channel, the market is segmented into direct tender and retail sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunoprotein Diagnostic Testing Market

A significant driver of the global immunoprotein diagnostic testing market is the rising incidence of chronic and infectious diseases, which is intensifying the need for precise and prompt diagnostic solutions. Immunoprotein testing is essential for the detection of various conditions, including cancer, autoimmune disorders, and infectious diseases. Moreover, increased awareness surrounding the importance of early disease identification, coupled with advancements in diagnostic technologies, is additionally propelling the growth of this market. As healthcare professionals prioritize timely interventions and accurate assessments, the demand for immunoprotein diagnostic tests continues to surge, further reinforcing the market's expansion.

Restraints in the Global Immunoprotein Diagnostic Testing Market

One of the critical challenges facing the Global Immunoprotein Diagnostic Testing market is the intricate and costly process involved in developing and implementing these tests. Creating reliable and specific immunoprotein diagnostic tests demands extensive research, development, and validation, which can be both time-consuming and resource-intensive. Additionally, the high costs associated with these tests can limit their accessibility, particularly in resource-constrained healthcare environments, thus hindering their broader adoption. This financial barrier not only affects the market's growth potential but also restricts the availability of advanced diagnostic solutions to various segments of the population, ultimately impacting overall market expansion.

Market Trends of the Global Immunoprotein Diagnostic Testing Market

The global immunoprotein diagnostic testing market is experiencing substantial growth, driven by a surge in the incidence of infectious and chronic diseases necessitating precise diagnostic solutions. Innovations in technology, particularly multiplex immunoassay platforms and point-of-care testing, are enhancing the speed and accuracy of diagnostics, fueling market expansion. The rising emphasis on personalized medicine and advancing biomarker research is bolstering the uptake of immunoprotein tests, as tailored therapies become more prevalent. Furthermore, strategic partnerships between industry leaders and research entities are fostering innovation and refining testing methodologies, positioning the market for robust growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Immunoprotein Diagnostic Testing Market Size by Test & CAGR (2024-2031)

• Market Overview
• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (Crp) Diagnostic Tests

Global Immunoprotein Diagnostic Testing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing

Global Immunoprotein Diagnostic Testing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Radioimmunoassay
• Enzyme Based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis

Global Immunoprotein Diagnostic Testing Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Global Immunoprotein Diagnostic Testing Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Direct Tender
• Retail Sales

Global Immunoprotein Diagnostic Testing Market Size & CAGR (2024-2031)

• North America (Test, Application, Technology, End Use, Distribution Channel)
  • USA
  • Canada
• Europe (Test, Application, Technology, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test, Application, Technology, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test, Application, Technology, End Use, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test, Application, Technology, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations